The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...

Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection) has been granted marketing ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

Feb. 3, 2025 — The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new ...

A saliva test may help "turn the tide" on prostate cancer, UK scientists claim. It analyses men's DNA to work out who was ...

“Our scans are getting better,” says ... People with mCRPC, or any advanced prostate cancer, may experience urinary problems, bone pain, fatigue, and weight loss — or possibly no symptoms ...

New research highlights the significance of timing and tumour location when evaluating PSMA PET scans following radiotherapy ...

Additionally, anemia occurs frequently with advanced prostate cancer. However, while prostate cancer can spread to the bone marrow like other cancers, one of the most common causes of anemia in ...

Those results also were reported in The New England Journal of Medicine. PSMA-PET scans of Michael Rosenblum before treatment (left) show prostate cancer metastases (small dark spots) throughout his ...

New Delhi: An international clinical trial has found that high-resolution ultrasound, known as micro-ultrasound (microUS), is as effective as MRI for diagnosing prostate cancer ... biopsies involve an ...

According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime. In addition, about 1 in 44 men will die from the ...